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Abstract
Background: Transfemoral venous access (TFV) is the cornerstone of minimally
invasive cardiac procedures. Although the presence of inferior vena cava filters
(IVCFs) was considered a relative contraindication to TFV procedures, small experiences have suggested safety. We conducted a systematic review of the available
literature on cardiac procedural success of TFV with IVCF in‐situ.
Methods: Two independent reviewers searched PubMed, EMBASE, SCOPUS, and
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Google Scholar from inception to October 2020 for studies that reported outcomes
in patients with IVCFs undergoing TFV for invasive cardiac procedures. We investigated a primary outcome of acute procedural success and reviewed the pooled
data for patient demographics, procedural complications, types of IVCF, IVCF dwell
time, and procedural specifics.
Results: Out of the 120 studies initially screened, 8 studies were used in the final
analysis with a total of 100 patients who underwent 110 procedures. The most
common IVCF was the Greenfield Filter (36%), 60% of patients were males and the
mean age was 67.8 years. The overall pooled incidence of acute procedural success
was 95.45% (95% confidence interval = 89.54–98.1) with no heterogeneity (I2 = 0%,
p = 1) and there were no reported filter‐related complications.
Conclusion: This systematic review is the largest study of its kind to demonstrate
the safety and feasibility of TFV access in a variety of cardiac procedures in the
presence of IVCF.
KEYWORDS

inferior vena cava filter, large bore venous access
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| INTRODUCTION

the left heart.1 Since then, many complex interventions utilizing TFV
access have been developed including leadless pacemaker implantation,

Transfemoral venous access (TFV) is integral to invasive cardiovascular

arrhythmia ablations, septal occluder device placement, transcatheter

procedures. Percutaneous balloon mitral valvuloplasty was one of the

valve‐in‐valve replacements, left atrial appendage occlusion, balloon

earliest structural heart interventions employing trans‐venous access to

valvuloplasty, and mechanical circulatory support placement.

Abbreviations: DVT, deep vein thrombosis; IVCF, inferior vena cava filter; TFV, transfemoral venous access.
Kuldeep Shah and Sati Patel contributed equally and are co‐first authors.
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Percutaneous inferior vena cava filters (IVCFs) are generally

the senior investigator (Nishaki Mehta). The following data from the

indicated to prevent venous thromboembolism in those with deep

eligible studies were extracted: author name, study design, publica-

vein thrombosis (DVT) or pulmonary embolism (PE) who have con-

tion year, follow‐up duration, number of patients, number of proce-

traindications to anticoagulation.2,3 Following the introduction of

dures, age, gender, duration of IVC filter, type of IVC filter, type of

percutaneous IVCFs in the 1970s, the annual implantation rate has

procedure, number of sheaths, catheters and their sizes, type of

markedly increased in the United States with 13% of patients with

anticoagulation, success, and complications. The Newcastle Ottawa

4–8

venous thromboembolism undergoing IVCF placement.

IVCFs are

not without risk and can be complicated by device thrombosis, mi-

Risk bias assessment tool was used to appraise the quality of included studies.

gration, embolization, perforation, and fracture.9–13 There are 17
types of filters available but only 53% are considered retrievable.14
In light of these complications and reports of guidewire entrapment,

2.3 | Outcomes

the presence of IVCF has been considered a relative contraindication
for cardiovascular procedures requiring transfemoral approach.15,16

The primary efficacy outcome of our study was acute procedural

However, recent studies have demonstrated the safety and feasi-

success (defined as ability to cross the IVC filter). In addition, we

bility of complex intracardiac procedures using TFV with catheter

reviewed the literature for causes of mortality, IVC thrombosis, and

passage through an IVCF.17–20 We sought to conduct a systemic

procedural complications.

review of available cardiovascular literature in patients with IVCF
undergoing cardiovascular procedures. We have also proposed a
workflow on the management approach in patients with IVCF.

3 |
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The meta‐analysis was performed using the meta package for R
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| METHODS

version 4.0 and RStudio version 1.2 (R Core Team). For pooled
analysis, we used Logit method to establish variance of raw pro-

2.1

| Search strategy

portions. Subsequently, we used DerSimonian–Laird random effect
model to combine the transformed proportions. Finally, we then back

The reporting of this systematic review was in compliance with

transformed the pooled estimates using generalized mixed linear

PRISMA (Preferred Reporting Items for Systematic Reviews and

models and plotted the data on the forest plot.22,23 Heterogeneity of

21

Meta‐Analysis) guidelines.

The initial search strategy was devel-

effect size among the included studies was assessed by Higgins

oped by two authors (Kuldeep Shah and Sati Patel). Systematic

I‐squared (I2) statistic.24 We used the Wan method to estimate mean

search, using PubMed, EMBASE, SCOPUS, and Google Scholar from

and standard deviation when median with interquartile range was

inception to October 25, 2020, for studies that had reported out-

reported.25

comes in patients with IVC filter that underwent TVA for invasive
procedures. We used the “AND” function to perform our literature
search (ivc filter) AND (femoral venous access), (ivc filter) AND

4 |
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(ablation), (ivc filter) AND (left atrial appendage), (ivc filter) AND
(mitral valve), (ivc filter) AND (leadless pacemaker).

4.1 | Search results and study characteristics
A total of 120 citations were identified during the initial search.

2.2

| Study selection and data extraction

After a detailed evaluation, 112 records were excluded, and 8
studies were included in the final analysis (Figure 1). This meta‐

The eligibility criteria for our systematic review included: (1) all

analysis of eight studies incorporated a total of 100 patients who

studies reporting data on TFV access in patients with IVCF and (2)

underwent 110 procedures.17–20,26–28 All studies included were

studies that included human subjects and published in the English

published between 2001 and 2020. The mean follow‐up period

language. The references of all identified articles were also reviewed

was 7 months, 60% of patients were males, and the mean age was

for relevant studies meeting the eligibility criteria. Case reports,

67.8 years. The mean duration of IVCF dwell time was 24 months.

editorials, or systematic reviews were excluded from our analysis.

The type of filter was reported in seven studies with Greenfield

Due to paucity of data, we decided to include case series with three

filter being the most common type (36%), though filter type was

or more patients. Two investigators (Kuldeep Shah and Sati Patel)

unknown or not reported in 26% patients (Figure 2).29 The

independently performed the literature search and screened all titles

number of sheaths or catheters traversing the IVC filter si-

and full‐text versions of all relevant studies that met study inclusion

multaneously ranged from 1 to 5 sheaths and/or catheters with

criteria. The data from included studies were extracted using a

cumulative French size ranging from 6 to 33 Fr. The detailed

standardized protocol and a data extraction form. Any discrepancies

baseline characteristics of patients included in our study and the

between the two investigators were resolved with consultation with

quality of studies are highlighted in Tables 1 and S1.
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F I G U R E 1 PRISMA flow diagram for studies
focusing on IVCF in invasive cardiology
procedures. IVCF, inferior vena cava filter;
PRISMA, Preferred Reporting Items for
Systematic Reviews and Meta‐analysis

4.2

| Acute procedural success

arterial approach was used instead.18 In the patient undergoing
leadless pacemaker implantation, various wires and sheaths were

The data for acute procedural success, defined as the ability to

used in attempts to cross the occluded IVCF, however, these efforts

successfully cross the IVCF was reported in all eight studies. The

were unsuccessful and ultimately the procedure was aborted

overall pooled incidence of acute procedural success was 95.45%

altogether.20 In one patient undergoing leadless pacemaker im-

(95% confidence interval [CI] = 89.54–98.1) with no heterogeneity

plantation, the IVCF was patent, however, there were multilevel

(I2 = 0%, p = 1; Figure 3). No study reported IVC filter‐related com-

stenoses in the venous system requiring balloon angioplasty of the

plications including entrapment, filter migration, or damage to the

right femoral vein, external iliac vein, and IVCF itself before the 27 Fr

filter integrity. The IVCF was occluded in three patients undergoing

introducer sheath could be safely introduced.20 No studies included

ventricular tachycardia (VT) ablations and in one patient undergoing

reported any instances of filter‐related complications including

leadless pacemaker implantation.18,20 In all three patients under-

entrapment/entanglement, filter migration, fracture, or embolic events.

going VT ablation, TFV access was abandoned and a retrograde

Of all studies, Houmsse et al.20 reported three in‐hospital mortalities,

FIGURE 2

Bar graph showing the number and different types of filters studied in the systematic review
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Sinha et al.
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2
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3

1
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96.7 ± 97.2 months

12(52)

73.8 ± 13.3

23

23

Retrospective

2020

Houmsse et al.

1

1
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81.4 ± 6.1

5

5

Retrospective

2019

El Ayech et al.

Trapease

Green field

2

2004

Year

Type of IVC filter

Awadalla et al.

Baseline characteristics of the studies included in the meta‐analysis

Study

TABLE 1
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0

Occluded IVC filter
10.1 ± 3.9 m

8.7 ± 9.5 m

1m

0

0

10

0

0

1

10

Kussmaul et al.

Mendelson et al.

3m

3

0

2

12

36

1.63 ± 0.48

1.68 ± 1.04

18.3 ± 11 m

0

0

2

19.75 ± 6.29

4

Rhodes et al.

1m

1

5

2.2 ± 0.84

14.4 ± 6.07

1

Sinha et al.

Abbreviations: EPS, electrophysiology study; IVC, inferior vena cava; LAAO, left atrial appendage occlusion; NOAC, novel oral anticoagulant; PFO, patent foramen ovale; RHC, right heart catheterization; SVT,
supraventricular tachycardia.

Follow‐up

1

0

Complications
1

8

None

0

6

NOAC

0

9

1

Warfarin

Anticoagulation

1

29.8 ± 3.94

1 ± 0.67

2

27

mean number of sheaths

12.8 ± 1.1
3.6 ± 0.52

25

sheath and catheter size

5

Kanjwal et al.

Mean number of catheters

3

PFO closure

RHC

LAAO

Leadless pacemaker

Temporary pacing
23

Houmsse et al.

3

El Ayech et al.

Lead extraction

Awadalla et al.
20

(Continued)

Ventricular Tachycardia ablation

Study

TABLE 1
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Forest plot of incidence of acute safety with IVCFs. IVCF, inferior vena cava filter

which were unrelated to the IVCF/EP procedure (septic shock,

these

endocarditis complication, and withdrawal of care for refractory HF).

perform.32,35,38–43

carry

their

own

risks

and

can

be

challenging

to

Several case reports and small case series have reported outcomes of intracardiac procedures with IVCFs in situ. Kussmaul

5

| DI SCUSSION

et al.26 first reported the ability to perform transfemoral right heart
catheterizations across IVCFs in 10 patients with Greenfield (Boston

Through this systematic review, we demonstrate a high procedural

Scientific) IVCFs without complication.26 This success highlighted

success rate (95%) using TFV access through IVCFs. To our knowl-

that the presence of IVCFs does not serve as a strict contraindication

edge, this is the only systematic review assessing the outcome of

to the transfemoral approach. Soon after, many reported the safety

cardiac procedures in patients requiring TFV access with pre‐existing

and feasibility of transfemoral structural heart interventions across

IVCF. We determined a high procedural success rate (95%). How-

IVCFs including septal occluder device placement, transcatheter

ever, patients with pre‐existing IVC thrombosis may pose procedural

percutaneous balloon mitral valvuloplasty, atrial septostomy, and

challenge and should be evaluated. IVC thrombosis has been re-

percutaneous mitral clip placement.27,28,44–46 Similarly, many EP

ported to occur in all IVCFs, with a higher incidence in those with

procedures have been successfully performed across a range of

30

retrievable filters, TrapEase (Cordis), and OptEase (Cordis) filters.

IVCFs including percutaneous defibrillator lead extraction, cavo-

Angel et al.10 in their systematic review found an overall 2.8%–8.8%

tricuspid isthmus ablations, leadless pacemaker implantation, and

incidence of vena cava thrombosis or stenosis in patients with IVCFs,

pulmonary vein isolation.41,47–54 In each of these interventions, au-

with a higher incidence in those with Option Filters. We report a 4%

thors advocate using direct fluoroscopic guidance when traversing

incidence of filter thrombosis in this systematic review consistent

the IVCF and most used preprocedural CT scans or venograms to

with prior reports. All cases required the use of alternative access

ensure filter patency. Several procedural modifications have been

sites or abandoning the procedure. When the TFV approach is not

suggested to avoid IVCF complications. For example, preprocedural

feasible, cardiovascular procedures have been successfully per-

CTs or venograms use of straight tipped or soft J‐tipped guide-

formed using alternative access sites.31–36 The transhepatic access

wires,26,44,51 first traversing the IVCF with the guidewire only to

offers the inferior approach familiar to operators for these proce-

ensure patency,18 and direct fluoroscopic guidance when traversing

dures. However, the transhepatic approach carries a greater risk of

the IVCF. Based on the aerial views of the filters, navigating

hematoma as it uses a noncompressible access site requiring vascular

circumferentially versus centrally can offer more room for passage of

plug or coil to achieve hemostasis. Additionally, the transhepatic

the sheaths. Utilizing multipurpose sheaths to redirect passage of the

approach may favor anterior catheter angulation, making transseptal

wires might permit more leeway (Figure 4). Collectively, these

puncture more challenging. Transhepatic access should therefore be

reports have supported the safety to navigate IVCFs during cardiac

performed at experienced centers to reduce complications, which

procedures.

may limit widespread applicability.32,35 Electrophysiology procedures

In our review, two high‐volume center studies accounted for

employing a superior approach via the superior vena cava have also

over 60% of the patients. These studies did not have routine pre‐

been reported.37–39 However, the superior approach carries a

procedure testing or contrast venogram unless there was difficulty

greater risk of operator radiation exposure as positioning is closer to

crossing the wire. In such instances, contrast injection and serial

the image intensifier. Further, catheter manipulation and contact can

dilation were utilized. Attempted procedures through an IVCF with

be challenging from a superior approach owing to lack of familiarity

either a partially or completely occluding thrombus may result in

and equipment not designed for this route.38,39 Though alternative

iatrogenic PE. Since our systematic review has a limited number of

procedural access sites can be considered in patients with IVCFs,

studies, we propose the following stepwise approach to all patients

SHAH
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with IVCFs undergoing intracardiac procedures from a transfemoral
approach based on the limited literature review and an informal
survey of experienced cardiologists. Pre‐procedurally, the type of
filter (manufacturer, retrievable vs. non‐retrievable) and dwell time
should be ascertained as well as the indication to support the ongoing need for the filter. The IVCF should then be crossed first with a
guidewire with possible use of multipurpose sheaths under direct
fluoroscopic guidance followed by over the wire passage of necesF I G U R E 4 Frontal and aerial views of three representative filters
(A, B: Vena‐Tech LGM filter; C, D: Simon nitinol filter; and E, F:
Greenfield filter) in the inferior vena cava (red outlines) and the blue
arrows indicate passage of the wire/sheath. As noted in the aerial
views, lateral or circumferential area for passage exceeds
central area

sary equipment. In cases in which there is difficulty in crossing the
filter with a wire, contrast injection should be performed. In higher‐
risk patients, especially those at high risk of vena cava thrombosis‐
such as those with retrievable filters, those not on anticoagulation,
and in those with specific filter types that harbor higher rates of
thrombosis, a pre‐procedure CT venogram or after obtaining TVA,
contrast venography may be considered in advance of wire passage

F I G U R E 5 Proposed algorithm for managing a patient with IVCF who presents for invasive cardiology procedure requiring transfemoral
access. IVCF, inferior vena cava filter

|
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to ensure filter patency. Similarly, all procedural equipment should

8.

be withdrawn under fluoroscopic guidance. At procedure completion,
IVCF positioning should be reviewed by fluoroscopy to ensure stable
filter positioning and integrity. If there is any concern, post‐

9.

procedure venogram can be performed. Finally, the necessity for
ongoing IVCF should be addressed and patients should be referred
for retrieval if appropriate (Figure 5).

10.

Due to the limited data on this topic, our systematic review is
confined by the small number of available studies. All studies in-

11.

cluded in our pooled analysis were single‐arm, non‐randomized studies (three case series, three retrospective, and only two prospective
studies), two large studies contribute to 60% of the patients and

12.

therefore subject to confounding factors. Additionally, the majority
of filters in the studies included were implanted for an average of
7 months (ranging from 1 month to 16 years), thus limiting applica-

13.

tion to more recently placed filters.
14.

6

| C O N CL U S I O N
15.

TVA is important to the success of a variety of invasive cardiac
procedures and IVCFs are not infrequently encountered. This systematic review and the current landscape of literature support the

16.

safe and effective passage of equipment through a variety of IVCFs
for complex EP and structural heart cases. We have also proposed an

17.

algorithmic approach for management based on our collative experiences and systematic review of the literature.
18.
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